Oncology - Oncology Xagena

Oncology

News

Drugs

Xagena Medicine

Xagena.net

Ovary removal surgery increases risk for dementia

Nanoparticles show promise in reducing radiation side effects

Signaling proteins may represent biomarkers for melanoma

Vegetables inhibit growth of prostate cancer in mice with human tumors

Ginkgo biloba extract inhibits growth of breast tumor in mouse model

Androgen deprivation therapy does not keep localized prostate cancer from spreading

Hepatic arterial infusion therapy improves survival for patients with colorectal cancer

Metastatic melanoma cells are reprogrammed in embryonic environment

Combined CHOP and HAART therapy improves AIDS-related lymphoma outcome

Atomic bomb survivors who had higher radiation exposure show increased incidence of thyroid diseases

Delayed intervention may combat overtreatment of prostate cancer

Depomedroxyprogesterone is effective treatment for hot flashes

Calcitriol reduces thrombosis in cancer patients

Lung cancer: Bortezomib extends survival 22 percent

Early breast cancer: better survival seen for patients switched from Tamoxifen to Exemestane

Apo2L selectively activates death receptors in cancer cells

Childhood cancer: polymorphisms in GSTP gene increase risk for congestive heart failure after treatment with anthracyclines

Sutent shows promise in children with metastatic GIST resistant to Imatinib

Advanced kidney cancer: Sutent shows significant benefits over Interferon-alpha

Head and neck cancer: Docetaxel combined with standard chemotherapy reduces mortality by nearly 30 percent

Breast cancer: Vitamin D and Calcium supplements have varied effects

HER-2 positive breast cancer: Herceptin added to radiation therapy

Brain metastases: Xcytrin extends cognitive function

Lung cancer: disease control rate may be a more powerful predictor of survival than tumor shrinkage

Preventive surgery reduces the risk of BRCA breast and ovarian cancers

Lung cancer: ICAM, a new predictor for treatment response and survival

Raloxifene and Tamoxifen are both effective in reducing the risk of invasive breast cancer but have different side effects

Sunitinib is a promising drug for treatment of metastatic renal cell cancer

Brain metastases: WBRT added to focused radiotherapy may reduce the likelihood of recurrences

Gleevec attacks prostate cancer in mouse model by destroying its blood supply

Next Pages 1 2 [3] 4 5 6 7 8 9 10 »

Link

• Allergology

• Biomedicine

• Dermatology

• Diabetology

• Diagnostics

• Drugs

• Endocrinology

• Gastroenterology

• Gene Medicine

• Infectivology

• Ophthalmology

• Pharmacology

• Rheumatology

• Stem Therapy

n Xagena.it

Powered by Luca Malattia - LM Web Solutions